MENS Stock Analysis: Buy, Sell, or Hold?
MENS - Jyong Biotech Ltd. Ordinary Shares
$2.22
0.17 (8.29%)
▲
5d:
+16.84%
30d:
+2.78%
90d:
-2.63%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When MENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MENS is currently trading at $2.22, which is considered extended relative to its 30-day fair value range of $1.67 to $2.14.
Technical Outlook: Technically, MENS is showing sideways momentum. Immediate support is located at $1.53, while resistance sits at $2.40. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: MENS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (77th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MENS is showing sideways momentum. Immediate support is located at $1.53, while resistance sits at $2.40. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: MENS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (77th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.67 -
$2.14
Company Quality Score
55/100
(HOLD)
Options IV Signal
77th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price extended above range
- BEARISH: Options expensive (IV 77th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
Trading Range Analysis
30-Day Trading Range
$1.67 -
$2.14
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.65
(29.2%)
Support & Resistance Levels
Support Level
$1.53
Resistance Level
$2.40
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 05, 2026 2:10 AM ET
Data refreshes hourly during market hours. Next update: 3:10 AM
Data refreshes hourly during market hours. Next update: 3:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MENS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |